Evidence map›Paper›PMID 40424189›Full record

ArticleeLife2025

Scrutinized lipid utilization disrupts Amphotericin-B responsiveness in clinical isolates of

Supratim Pradhan, Dhruba Dhar, Debolina Manna, Shubhangi Chakraborty, Arkapriya Bhattacharyya, Khushi Chauhan, Rimi Mukherjee, Abhik Sen, Krishna Pandey, Soumen Das and 1 more

Erratum issuedAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in eLife, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Supratim PradhanSchool of Medical Science and Technology, Indian Institute of Technology Kharagpur, Kharagpur, India.ORCID https://orcid.org/0009-0003-6573-8196
Dhruba DharSchool of Medical Science and Technology, Indian Institute of Technology Kharagpur, Kharagpur, India.
Debolina MannaSchool of Medical Science and Technology, Indian Institute of Technology Kharagpur, Kharagpur, India.
Shubhangi ChakrabortySchool of Medical Science and Technology, Indian Institute of Technology Kharagpur, Kharagpur, India.
Arkapriya BhattacharyyaSchool of Medical Science and Technology, Indian Institute of Technology Kharagpur, Kharagpur, India.
Khushi ChauhanSchool of Medical Science and Technology, Indian Institute of Technology Kharagpur, Kharagpur, India.
Rimi MukherjeeICMR-Rajendra Memorial Research Institute of Medical Sciences, Patna, India.
Abhik SenICMR-Rajendra Memorial Research Institute of Medical Sciences, Patna, India.
Krishna PandeyICMR-Rajendra Memorial Research Institute of Medical Sciences, Patna, India.
Soumen DasSchool of Medical Science and Technology, Indian Institute of Technology Kharagpur, Kharagpur, India.
Budhaditya MukherjeeSchool of Medical Science and Technology, Indian Institute of Technology Kharagpur, Kharagpur, India.ORCID https://orcid.org/0000-0002-1058-3620

Funding

Council of Scientific and Industrial Research CSIR fellowshipCouncil of Scientific and Industrial Research GATE fellowshipPrime Minister's Research Fellowship 2021-2024University Grants Commission India CSIR-UGC (2020-2021) fellowship
6 · The paper itself

Abstract

The management of

Indexed as

Amphotericin BAntiprotozoal AgentsLeishmania donovaniLeishmaniasis, VisceralLipid MetabolismAnimalsFemaleHumansMacrophagesMiceMice, Inbred BALB CAmphotericin BAntiprotozoal Agentscell biologyclinical Leishmania donovani isolatesdrug unresponsivenessinfectious diseaseLDL-cholesterollipid dropletsmicrobiologymousevesicle fusion

Identifiers

PMID40424189
PMCPMC12113272

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.